Ocular Synkinesis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-07-19
Clinical Trial Update: Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis [Phase 4]
A Phase 4 trial evaluating topical apraclonidine for ocular synkinesis associated with facial nerve palsy has been withdrawn.